Nanotechnology used to engineer ACL replacements

Lindsey Vonn. Derrick Rose. Tom Brady. Mickey Mantle.

They have all fallen victim to the dreaded pop of the knee.

Connecting the femur to the tibia, the anterior cruciate ligament (ACL) rupture is one of the most devastating injuries in sports. No other injury has sidelined more athletes for a season or even the rest of a career. And ACL sprains and tears affect more people than just the pros. According to the American Association of Orthopaedic Surgeons, more than 250,000 ACL surgeries are performed annually in the United States, totaling up to more than $500 million in health care costs each year.

Not only is the ACL inelastic and prone to popping, it is incapable of healing itself, causing surgeons to rely on autografts for reconstruction. Most common is the bone-patellar tendon-bone (BPTB) graft, in which the surgeon removes part of the patellar tendon to replace the damaged ACL.

"BPTB autografts have a high incidence of knee pain and discomfort that does not go away," said Guillermo Ameer, professor of biomedical engineering at Northwestern University's McCormick School of Engineering and professor of surgery at the Feinberg School of Medicine. "By saving the patient's patellar tendon and using an off-the-shelf product, one may have a better chance of preserving the natural biomechanics of the knee."

Ameer and his research team are working to engineer such a product by combining three components: polyester fibers that are braided to increase strength and toughness, an inherently antioxidant and porous biomaterial previously created in Ameer's lab, and calcium nanocrystals, a mineral naturally found in human teeth and bones. His work is described in the paper "A biodegradable tri-component graft for anterior cruciate ligament reconstruction," which was published in the Nov. 21 issue of the Journal of Tissue Engineering and Regenerative Medicine. Eunji Chung, a postdoc at the University of Chicago and former graduate student in Ameer's lab, was the paper's first author.

During ACL reconstruction surgeries, tunnels are drilled into the femur and tibia bones to hold the new ligament in a fixed position. Ameer created a bone-like material by combining his antioxidant biomaterials with the calcium nanocrystals; he then embedded braided polyester fibers into it. The artificial ligament's bone-like ends healed to the native bone in the drilled tunnels, anchoring the ligament into place.

By studying an animal model, Ameer and his team noticed that the animal's natural bone and tissue cells migrated into the pores of the artificial ligament, populating it throughout and integrating with the bone tunnels. While longer-term studies are necessary to evaluate the potential use of the approach in humans, Ameer is optimistic about the results.

"The engineered ligament is biocompatible and can stabilize the knee, allowing the animal to function," Ameer said. "Most importantly, we may have found a way to integrate an artificial ligament with native bone."

Story Source:

Original post:

Nanotechnology used to engineer ACL replacements

Researchers use nanotechnology to engineer ACL replacements

Researchers created a tri-component, synthetic graft for reconstructing torn anterior cruciate ligaments

Lindsey Vonn. Derrick Rose. Tom Brady. Mickey Mantle.

They have all fallen victim to the dreaded pop of the knee.

Connecting the femur to the tibia, the anterior cruciate ligament (ACL) rupture is one of the most devastating injuries in sports. No other injury has sidelined more athletes for a season or even the rest of a career. And ACL sprains and tears affect more people than just the pros. According to the American Association of Orthopaedic Surgeons, more than 250,000 ACL surgeries are performed annually in the United States, totaling up to more than $500 million in health care costs each year.

Not only is the ACL inelastic and prone to popping, it is incapable of healing itself, causing surgeons to rely on autografts for reconstruction. Most common is the bone-patellar tendon-bone (BPTB) graft, in which the surgeon removes part of the patellar tendon to replace the damaged ACL.

"BPTB autografts have a high incidence of knee pain and discomfort that does not go away," said Guillermo Ameer, professor of biomedical engineering at Northwestern University's McCormick School of Engineering and professor of surgery at the Feinberg School of Medicine. "By saving the patient's patellar tendon and using an off-the-shelf product, one may have a better chance of preserving the natural biomechanics of the knee."

Ameer and his research team are working to engineer such a product by combining three components: polyester fibers that are braided to increase strength and toughness, an inherently antioxidant and porous biomaterial previously created in Ameer's lab, and calcium nanocrystals, a mineral naturally found in human teeth and bones. His work is described in the paper "A biodegradable tri-component graft for anterior cruciate ligament reconstruction," which was published in the Nov. 21 issue of the Journal of Tissue Engineering and Regenerative Medicine. Eunji Chung, a postdoc at the University of Chicago and former graduate student in Ameer's lab, was the paper's first author.

During ACL reconstruction surgeries, tunnels are drilled into the femur and tibia bones to hold the new ligament in a fixed position. Ameer created a bone-like material by combining his antioxidant biomaterials with the calcium nanocrystals; he then embedded braided polyester fibers into it. The artificial ligament's bone-like ends healed to the native bone in the drilled tunnels, anchoring the ligament into place.

By studying an animal model, Ameer and his team noticed that the animal's natural bone and tissue cells migrated into the pores of the artificial ligament, populating it throughout and integrating with the bone tunnels. While longer-term studies are necessary to evaluate the potential use of the approach in humans, Ameer is optimistic about the results.

"The engineered ligament is biocompatible and can stabilize the knee, allowing the animal to function," Ameer said. "Most importantly, we may have found a way to integrate an artificial ligament with native bone."

More:

Researchers use nanotechnology to engineer ACL replacements

Microscopy Market Hit to $5,756.0 Million by 2019 – New Research Report by MarketsandMarkets

(PRWEB) December 26, 2014

The microscopy market is estimated to grow at a CAGR of 7.2% to reach $5,756.0 million by 2019. Optical microscopy is the largest segment of the microscopy market. The electron microscopes product segment is expected to show the fastest growth during the forecast period.

Rising focus on nanotechnology, technological advancements, and increasing federal support to drive growth of the microscopy market.

Get Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html

Developing markets such as the Middle East, Brazil, Argentina, Mexico, China, and India are lucrative markets for microscopy, owing to favorable government incentives and corporate funding.

The report segments the global microscopy market by product, application, end user, and geography. The optical microscopy segment accounted for the largest share of the global microscopy market, by product. However, the electron microscopes segment is expected to grow at the highest CAGR in the forecast period. Super-resolution microscopes are the key playing field in the microscopy product market, owing to ongoing technological advancements in this segment.

Speak to Analyst @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=399

On the basis of applications, the microscopy market is categorized into semiconductors, life sciences, nanotechnology, and material science. Nanotechnology is expected to be the new revenue pocket in the application market. Rising focus on nanotechnology, favourable government and corporate funding, and technological advancements are propelling the growth of these segments.

Academic institutes are the major end user of the microscopy market, followed by industries. The large share of this segment can be attributed to increase in research activities and favourable government funding.

New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

See the original post:

Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets

Local Vets Using Nanotechnology To Help Pets Healing

PITTSBURGH (KDKA) Modern medicine is evolving quickly.

Now, with the introduction of bioengineering, doctors can have tissue made for their patients and veterinarians are having great success using nanotechnology in our pets.

Dr. Jed Johnson has a PhD in engineering and his firm engineers body tissue.

The part that I focus on is tissue engineering, where we are basically focusing and building or engineering new tissue for the body, Dr. Johnson said.

Their nanotechnology is an integral part of regenerative medicine.

Weve all seen regeneration. Weve all had cuts on our hands, right? And those cuts heal. So, our body is capable of healing, but we have to provide the right environment, Dr. Johnson said.

Enter nanofibers.

It takes a hundred of the microscopic fibers laid side-by-side to be as wide as a human hair.

Weave them together, and they provide a framework for healing.

Cells and tissue cant move across open space, they have to crawl on something, and this is really the key aspect to having a scaffold is it allows those cells to have a highway to move on to refill that wound, regenerate that native tissue, Dr. Johnson said.

Read this article:

Local Vets Using Nanotechnology To Help Pets Healing

Functional Considerations & Opportunities for Nanocomposites & Nanotechnology in Commercial Airspace – Video


Functional Considerations Opportunities for Nanocomposites Nanotechnology in Commercial Airspace
Presentation by Russ Maguire, President of Global Nanocomposites, at the 2015 JCATI Research Symposium.

By: JCATI Video

Here is the original post:

Functional Considerations & Opportunities for Nanocomposites & Nanotechnology in Commercial Airspace - Video

Nanotechnology Against Malaria Parasites Could Lead To Treatment, Vaccination Strategies

December 11, 2014

Image Caption: After maturation, malaria parasites (yellow) are leaving an infected red blood cell and are efficiently blocked by nanomimics (blue). (Fig: Modified with permission from ACS).

Provided by University of Basel

Malaria parasites invade human red blood cells, they then disrupt them and infect others. Researchers at the University of Basel and the Swiss Tropical and Public Health Institute have now developed so-called nanomimics of host cell membranes that trick the parasites. This could lead to novel treatment and vaccination strategies in the fight against malaria and other infectious diseases. Their research results have been published in the scientific journal ACS Nano.

For many infectious diseases no vaccine currently exists. In addition, resistance against currently used drugs is spreading rapidly. To fight these diseases, innovative strategies using new mechanisms of action are needed. The malaria parasite Plasmodium falciparum that is transmitted by the Anopheles mosquito is such an example. Malaria is still responsible for more than 600,000 deaths annually, especially affecting children in Africa (WHO, 2012).

Artificial bubbles with receptors

Malaria parasites normally invade human red blood cells in which they hide and reproduce. They then make the host cell burst and infect new cells. Using nanomimics, this cycle can now be effectively disrupted: The egressing parasites now bind to the nanomimics instead of the red blood cells.

Researchers of groups led by Prof. Wolfgang Meier, Prof. Cornelia Palivan (both at the University of Basel) and Prof. Hans-Peter Beck (Swiss TPH) have successfully designed and tested host cell nanomimics. For this, they developed a simple procedure to produce polymer vesicles small artificial bubbles with host cell receptors on the surface. The preparation of such polymer vesicles with water-soluble host receptors was done by using a mixture of two different block copolymers. In aqueous solution, the nanomimics spontaneously form by self-assembly.

Blocking parasites efficiently

Usually, the malaria parasites destroy their host cells after 48 hours and then infect new red blood cells. At this stage, they have to bind specific host cell receptors. Nanomimics are now able to bind the egressing parasites, thus blocking the invasion of new cells. The parasites are no longer able to invade host cells, however, they are fully accessible to the immune system.

Read more:

Nanotechnology Against Malaria Parasites Could Lead To Treatment, Vaccination Strategies

Nanotechnology against malaria parasites

Malaria parasites invade human red blood cells, they then disrupt them and infect others. Researchers at the University of Basel and the Swiss Tropical and Public Health Institute have now developed so-called nanomimics of host cell membranes that trick the parasites. This could lead to novel treatment and vaccination strategies in the fight against malaria and other infectious diseases. Their research results have been published in the scientific journal ACS Nano.

For many infectious diseases no vaccine currently exists. In addition, resistance against currently used drugs is spreading rapidly. To fight these diseases, innovative strategies using new mechanisms of action are needed. The malaria parasite Plasmodium falciparum that is transmitted by the Anopheles mosquito is such an example. Malaria is still responsible for more than 600,000 deaths annually, especially affecting children in Africa (WHO, 2012).

Artificial bubbles with receptors

Malaria parasites normally invade human red blood cells in which they hide and reproduce. They then make the host cell burst and infect new cells. Using nanomimics, this cycle can now be effectively disrupted: The egressing parasites now bind to the nanomimics instead of the red blood cells.

Researchers of groups led by Prof. Wolfgang Meier, Prof. Cornelia Palivan (both at the University of Basel) and Prof. Hans-Peter Beck (Swiss TPH) have successfully designed and tested host cell nanomimics. For this, they developed a simple procedure to produce polymer vesicles -- small artificial bubbles -- with host cell receptors on the surface. The preparation of such polymer vesicles with water-soluble host receptors was done by using a mixture of two different block copolymers. In aqueous solution, the nanomimics spontaneously form by self-assembly.

Blocking parasites efficiently

Usually, the malaria parasites destroy their host cells after 48 hours and then infect new red blood cells. At this stage, they have to bind specific host cell receptors. Nanomimics are now able to bind the egressing parasites, thus blocking the invasion of new cells. The parasites are no longer able to invade host cells, however, they are fully accessible to the immune system.

The researchers examined the interaction of nanomimics with malaria parasites in detail by using fluorescence and electron microscopy. A large number of nanomimics were able to bind to the parasites and the reduction of infection through the nanomimics was 100-fold higher when compared to a soluble form of the host cell receptors. In other words: In order to block all parasites, a 100 times higher concentration of soluble host cell receptors is needed, than when the receptors are presented on the surface of nanomimics.

"Our results could lead to new alternative treatment and vaccines strategies in the future," says Adrian Najer first-author of the study. Since many other pathogens use the same host cell receptor for invasion, the nanomimics might also be used against other infectious diseases. The research project was funded by the Swiss National Science Foundation and the NCCR "Molecular Systems Engineering."

Story Source:

More here:

Nanotechnology against malaria parasites

The Microscopy Market Is Expected to Reach $5,756.0 Million by 2019 – New Report by MarketsandMarkets

(PRWEB) December 08, 2014

Microscopy Market by Product [Optical (Fluorescence, Super Resolution), Confocal, Electron (Transmission), Scanning (AFM)], by Application (Semiconductor, Life Science, Nanotechnology), End User (Academic Institute, Industries) Global Forecast to 2019 provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

Get Copy of this Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html Early buyers will receive 10% customization on this report.

The global microscopy market is poised to reach $5,756.0 million by 2019 from $4,065.8 million in 2014, at a CAGR of 7.2% from 2014 to 2019.

Factors such as rising global focus on nanotechnology, favourable government and corporate funding, and technological advancements such as super resolution microscopy, high-throughput techniques, and digitization of microscopes are driving the microscopy market. However, the high cost of advanced microscopes; implementation of excise tax by the U.S. government; and the heavy custom duty on medical devices are hindering the growth of this market.

For Report Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=399

The microscopy market is segmented on the basis of product, application, end user, and region. On the basis of type of product, the microscopy market is broadly segmented into optical microscopes, confocal microscopes, electron microscopes, and scanning probe microscopes. The optical microscopy segment is further divided into fluorescence microscopy (FM) and super-resolution microscopy. The fluorescence microscopy segment is divided into total internal reflection fluorescence microscopy (TIRF), fluorescence resonance energy transfer (FRET), fluorescence recovery after photo-bleaching (FRAP), and fluorescence lifetime imaging microscopy (FLIM). The super-resolution microscopy is sub-segmented into stochastic optical reconstruction microscopy (STORM), structured illumination microscopy (SIM), stimulated emission depletion microscopy (STED), coherent anti-strokes Raman scattering microscopy (CARS), photo-activated localization microscopy (PALM), and reversible saturable optical fluorescence transitions (RESOLFT). The confocal microscopy is segmented into multi-photon microscopy and confocal disk spinning microscopy. Electron microscopy is segmented into transmission electron microscopy (TEM) and scanning electron microscopy (SEM). The scanning probe microscopy segment is further divided into scanning tunnelling microscopy (STM), atomic force microscopy (AFM), and near-field scanning optical microscopy (NSOM). The optical microscopy segment accounted for the largest share39.5%of the global microscopy market in 2014.

The microscopy applications market is categorized into semiconductors, life sciences, nanotechnology, and material science. In this market, Nanotechnology is the fastest growing application. On the basis of end users, the microscopy market is classified into academic institutes, industries, and others (government research institutes and private laboratories). In this market, academic institutes are the major end users.

Ask for PDF Manual @ http://www.marketsandmarkets.com/pdfdownload.asp?id=399

On the basis of geography, the microscopy market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). RoW is further segmented into Brazil, Argentina, Mexico and Rest of Latin America. In 2014, North America is expected to account for the largest share of the microscopy market, followed by Europe. Both markets are estimated to register single-digit growth rates over the next five years.

Go here to read the rest:

The Microscopy Market Is Expected to Reach $5,756.0 Million by 2019 - New Report by MarketsandMarkets